Skip Ribbon Commands
Skip to main content
Navigate Up

Exciting Announcement: New CAMH.CA website is launching late April 2018

Annual Report to the Community 2010-2011 Centre for Addiction
and Mental Health


Previous PageNext Page


CAMH is uniquely positioned to make discoveries that benefit people with mental illness and addictions.

“From neuron to neighbourhood,” our integrative approach to research encompasses genetics, molecular neuroscience and brain imaging, clinical and community-based studies, and epidemiological, social and policy research. Our research has a common goal—to improve the lives of people with mental illness and addictions.

Six CAMH scientists hold Canada Research Chairs

Through our Research Renaissance Project, our capacity to leverage this integrative approach will grow in the coming years. This investment into research infrastructure has provided the momentum to unravel causes, and discover effective prevention and treatment approaches.

Research that is transforming care

Mental illness in later life

CAMH has a strong research program focused on aging and mental health. Over the past year, our scientists have made discoveries in both prevention and treatment. In prevention, Dr. Aristotle Voineskos used an innovative combination of brain imaging and genetic analysis to identify healthy people at risk for late-onset Alzheimer’s disease. He identified a genetic variation of a protein that may play a role in Alzheimer’s. The protein, a brain-derived neurotrophic factor, is essential for learning and memory functions.

Drs. Aristotle Voineskos (l) and Tarek Rajji.
Drs. Aristotle Voineskos (l) and Tarek Rajji in front of an image of a transcranial magnetic stimulation coil applied to the brain.

More than half of people with Alzheimer’s disease experience distressing symptoms such as delusions, hallucinations or agitation, and they are often treated with antipsychotic drugs such as risperidone. A study by Drs. Bruce G. Pollock and Robert Bies found that high concentrations of the drug’s by-product led to people quitting their medication because it was not working or because of side-effects. Dr. Pollock is currently co-leading a multi-site study of a potential alternative treatment, supported by the U.S. National Institute on Aging and National Institute of Mental Health.

A number of mental illnesses are associated with problems with memory, attention and planning, and other cognitive deficits. The presence of these deficits can predict how well people function in their daily lives.

CAMH Switchboard 416-535-8501
CAMH General Information Toronto: 416-595-6111 Toll Free: 1-800-463-6273
Connex Ontario Help Lines
Queen St.
1001 Queen St. W
Toronto, ON
M6J 1H4
Russell St.
33 Russell St.
Toronto, ON
M5S 2S1
College St.
250 College St.
Toronto, ON
M5T 1R8
Ten offices across Ontario